FREDERICK, MD--(Marketwire - November 03, 2011) -
| Highlighted Links |
|
|
BioElectronics Corporation (PINKSHEETS: BIEL) (OTCQB: BIEL), the maker of inexpensive, disposable drug-free topical pain and healing devices, today announced the publication of an article in the peer reviewed journal Aesthetic Plastic Surgery that demonstrates the effective use of BioElectronics Corporation Pulsed Radio Frequency Energy (PRFE) therapy to reduce postoperative pain.
“Postoperative pain is still a major problem that continues to be undertreated. There are significant benefits to controlling postoperative pain, including faster surgical recovery with fewer postsurgical complications. With this published study BioElectronics clearly shows that its innovative medical devices can significantly contribute to patients experiencing a decreased amount of postoperative pain. In this particular clinical study, there was at least a 50% reduction in postoperative pain compared to the placebo group,” commented Ian Rawe, PhD, BioElectronics Director of Clinical Research. “We are progressing with larger clinical studies, for example, our 200 patient C-section recovery study, and are confident that these clinical studies will produce results that support, and add to the finding presented in this published article.”
“It has been clear to us for a long time that our products reduce the amount of patient pain when recovering from a soft tissue injury,” commented Arnon Horev, BioElectronics VP Sales and Marketing. “We believe that peer reviewed publication of our clinical studies can only benefit BioElectronics in gaining greater recognition and acceptance of our innovative products in the medical community.”
The article, titled, “Control of Postoperative Pain with a Wearable Continuously Operating Pulsed Radiofrequency Energy Device: A Preliminary Study” can be viewed at: http://www.ncbi.nlm.nih.gov/pubmed/22037572
About BioElectronics Corporation
BioElectronics is an award winning medical device developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal complaints, the Allay™ Menstrual Cycle Pain Therapy, and RecoveryRx™ for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care to reduce soft tissue pain and swelling. For more information, please see www.bielcorp.com.
Contact:
Ben Fichter
BioElectronics Corporation
(301) 874-4890
Digg this
Bookmark with del.icio.us
Add to Newsvine
Technorati: 
